2019
DOI: 10.1038/s41586-019-1831-x
|View full text |Cite
|
Sign up to set email alerts
|

Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis

Abstract: Oncogenic activation of Ras is associated with the acquisition of a unique set of metabolic dependencies that contribute to tumor cell fitness. Mutant Ras cells are endowed with the capability to internalize and degrade extracellular protein via a fluid-phase uptake mechanism termed macropinocytosis 1 . There is a growing appreciation for the role of this Ras-dependent process in the generation of free amino acids that can be used to support tumor cell growth under nutrient limiting conditions 2 . However, lit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

10
114
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 131 publications
(124 citation statements)
references
References 37 publications
(48 reference statements)
10
114
0
Order By: Relevance
“…However, in the case of oncogenic Ras, activation of Rac is dependent on the activity of the V-ATPase along with its relocation to the plasma membrane (40). Importantly, the activation ERK1/2 MAPK signaling by VopQ does not occur through the growth factor inducible Rasmediated pathway, but instead is dependent on the kinase activity of the ER stress sensor and cell-fate executor, IRE1 (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…However, in the case of oncogenic Ras, activation of Rac is dependent on the activity of the V-ATPase along with its relocation to the plasma membrane (40). Importantly, the activation ERK1/2 MAPK signaling by VopQ does not occur through the growth factor inducible Rasmediated pathway, but instead is dependent on the kinase activity of the ER stress sensor and cell-fate executor, IRE1 (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Rac1 has been consistently involved in the activation of pro-survival pathways in cancer cells, such as NF-κB, thereby counterbalancing the apoptotic responses triggered by chemotherapeutic agents and radiation therapy (Friedland et al, 2007;Han et al, 2013;Wang et al, 2013Wang et al, , 2016Hein et al, 2016). Regarding cellular metabolism, Rac1 has been widely associated with macropinocytosis, a mechanism of endocytic uptake of extracellular fluid that assists in meeting the increased demand of nutrients required for cancer cells to proliferation (Erami et al, 2017;Ramirez et al, 2019). In NSCLC cells, PI3K/Rac1/Pak1-driven macropinocytosis and engulfing of extracellular proteins represents an adaptive metabolic pathway for surviving in states of glucose deprivation (Hodakoski et al, 2019).…”
Section: Location Is the Key: Why Do Cancer Cells Need Multiple Rac-gmentioning
confidence: 99%
“…V-type H + -ATPases (V-ATPases) have also been studied in the context of cancer [6,7]. In contrast to NHE1, NBCs and MCTs, V-ATPases predominantly localize to endosomes and lysosomes, the Golgi apparatus, and other intracellular compartments [8][9][10][11][12][13] and are only found in the plasma membrane in specialized cell types and some cancer cells [6,14,15]. V-ATPases play a pivotal role in controlling the luminal pH of endosomes, lysosomes, and the Golgi apparatus [6,7,14,16].…”
Section: Of 22mentioning
confidence: 99%
“…In contrast to NHE1, NBCs and MCTs, V-ATPases predominantly localize to endosomes and lysosomes, the Golgi apparatus, and other intracellular compartments [8][9][10][11][12][13] and are only found in the plasma membrane in specialized cell types and some cancer cells [6,14,15]. V-ATPases play a pivotal role in controlling the luminal pH of endosomes, lysosomes, and the Golgi apparatus [6,7,14,16]. Through this, as well as through acidification-independent scaffolding functions, they regulate endocytic trafficking, autophagy, macropinocytosis, lysosomal degradation, metabolism, protein glycosylation, and signaling pathways including notch-, Wnt-, and epidermal growth factor receptor (EGFR) signaling [6,7,[14][15][16].…”
Section: Of 22mentioning
confidence: 99%
See 1 more Smart Citation